Novozymes received GRAS (Generally Regarded As Safe) notice from the US FDA (Federal Drug Administration) for Acrylaway in November 2006, being the first product of its kind to receive that notice.
Click here for more information about the GRAS notice for Acrylaway.
In June 2007, Acrylaway received regulatory approval from the Danish authorities and is therefore the only asparaginase that has actively been safety evaluation by an EU authority.
For specific regulatory status in a country on the use of Acrylaway in food, please contact Novozymes’ account managers
